Ads block
Showing posts with label Health. Show all posts
Showing posts with label Health. Show all posts
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
The company said it would share the study’s interim data with health authorities with the aim of bringing the treatment to the market as soon as possible. Read…
Read more »
A Spotify founder’s company selling full-body scans has come to the U.S. Read more in this week’s WSJ Wellness newsletter.
Neko Health, a Spotify founder’s preventative-health startup, opened its first U.S. clinic. Plus, chemicals in natural-fiber clothing and the real culprit for …
Read more »
A Spotify founder’s company selling full-body scans has come to the U.S. Read more in this week’s WSJ Wellness newsletter.
Neko Health, a Spotify founder’s preventative-health startup, opened its first U.S. clinic. Plus, chemicals in natural-fiber clothing and the real culprit for …
Read more »
A Spotify founder’s company selling full-body scans has come to the U.S. Read more in this week’s WSJ Wellness newsletter.
Neko Health, a Spotify founder’s preventative-health startup, opened its first U.S. clinic. Plus, chemicals in natural-fiber clothing and the real culprit for …
Read more »
Health Care Roundup: Market Talk
Find insight on AstraZeneca, Q/C Technologies and more in the latest Market Talks covering the health care sector. Read Full Story →
Read more »
States haven’t yet been able to obtain Covid-19 shots from the CDC, delaying their distribution to millions of children through federal programs, according to people familiar with the matter
The Centers for Disease Control and Prevention hasn’t opened up the ordering process, raising concerns about delays as vaccination programs kick off. Read Full…
Read more »
It’s been a big week for Hyrox. Read more in this week’s WSJ Wellness newsletter.
Plus, energy-drink crackdowns and bodega peptides. Read Full Story →
Read more »
Hospitals and doctor’s offices are increasingly asking patients to foot the bill ahead of medical procedures
Hospitals and doctor’s offices are increasingly asking patients to foot the bill ahead of medical procedures. Read Full Story →
Read more »
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
The company said it would share the study’s interim data with health authorities with the aim of bringing the treatment to the market as soon as possible. Read…
Read more »
It’s been a big week for Hyrox. Read more in this week’s WSJ Wellness newsletter.
Plus, energy-drink crackdowns and bodega peptides. Read Full Story →
Read more »
Oura and other health trackers spit out wrong numbers sometimes. Doctors say they can still be useful—@nicnguyen explains why.
Health trackers might spit out unreliable numbers, but doctors say they’re still useful for spotting personal trends. Read Full Story →
Read more »
Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.
The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S. Read Full Story →
Read more »
Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.
The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S. Read Full Story →
Read more »
Legend Biotech has tapped a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July
Ingrid Zhang is taking the helm of the cancer therapy company, filling a post vacant since its previous CEO abruptly resigned in July. Read Full Story →
Read more »
Wegovy maker Novo Nordisk is rebranding as Novo, betting a shorter name will help it resonate more with consumers as it competes with rival Eli Lilly.
The Wegovy maker is betting that a shorter name will help it resonate more with consumers as it competes with rival Eli Lilly. Read Full Story →
Read more »
Facial filler is out, fat grafting is in. Read more in this week’s WSJ Wellness newsletter.
The popularity of GLP-1s is shifting facial aesthetic trends. Plus, a fast-food chain that’s gone full MAGA and back-to-school morning routines. Read Full Stor…
Read more »
Might I be a candidate for a bit of T-maxxing?
Driven by internet trends and fatigue, I decided to test my testosterone levels—only to uncover the complicated science and hidden anxieties behind modern masc…
Read more »
Here’s how to understand Oura ring sleep scores. Read more in this week’s WSJ Wellness newsletter.
People are going to great lengths to optimize their sleep. Plus, the boomers living with their parents in retirement communities and the tech billionaires tryi…
Read more »
Travel can still be a big part of someone’s life, even when living with dementia. But there are challenges for caregivers.
Families navigating cognitive decline are taking to the road to chase joy before an advancing disease makes trips impossible. Read Full Story →
Read more »
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
A committee said the volrustomig combination was unlikely to reach either of the primary endpoints for the trial, but the company said other Phase 3 volrustomi…
Read more »
-
Our global transition to renewable energy sources like solar and wind is critical for combating climate change. However, these sources a...
-
Large Language Models (LLMs) function as sophisticated statistical prediction machines built upon a neural network architecture called ...
-
Compound interest is the single most powerful force in finance, often called the " eighth wonder of the world ." If you want to...
Subscribe Us
Click a video to watch:
